Application Of Gene Engineering In The Treatment Of Patients With Covid-19

Abstract

Modern therapeutic options for the treatment of COVID-19 combine the use of drugs that affect both the virus itself and the components of the body's immune response. Despite the fact that the pathogenetic mechanisms of the infectious disease have been partially investigated, treatment methods still do not live up to expectations, which is largely due to the development of adverse drug reactions and conflicting treatment results. This situation necessitates the analysis of modern scientific sources regarding the prospects, advantages and disadvantages of the use of virus-neutralizing monoclonal antibodies, natural killers, mesenchymal stem cells and monoclonal antibodies to interleukin-6.